We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+0.72%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+505.55%
AUM
$304B
AUM Growth
-$14.5B
Cap. Flow
-$11.3B
Cap. Flow %
-3.72%
Top 10 Hldgs %
15.32%
Holding
7,717
New
593
Increased
2,914
Reduced
3,244
Closed
656

Sector Composition

Rank Sector Weight
1 Financials 8.59%
2 Technology 8.45%
3 Healthcare 7.6%
4 Consumer Discretionary 6.86%
5 Energy 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLCT
5651
DELISTED
Collectors Universe
CLCT
$169K ﹤0.01%
10,190
-5,978
-37% -$92.7K
FUEL
5652
DELISTED
Rocket Fuel Inc.
FUEL
$169K ﹤0.01%
53,658
-54,035
-50% -$175K
XNPT
5653
DELISTED
XENOPORT, INC.
XNPT
$169K ﹤0.01%
37,420
-137,341
-79% -$633K
CSBK
5654
DELISTED
Clifton Bancorp Inc.
CSBK
$169K ﹤0.01%
+11,181
New +$162K
ATYR
5655
aTyr Pharma
ATYR
$51.9M
$168K ﹤0.01%
3,054
+2,100
+220% +$160K
DRNA
5656
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$167K ﹤0.01%
31,172
+15,373
+97% +$97K
MDR
5657
PUT
DELISTED
McDermott International
MDR
$167K ﹤0.01%
13,633
-8,734
-39% -$82.9K
AVDL
5658
DELISTED
Avadel Pharmaceuticals
AVDL
$166K ﹤0.01%
+15,000
New +$149K
AXDX
5659
DELISTED
Accelerate Diagnostics
AXDX
$166K ﹤0.01%
1,156
+32
+3% +$4.52K
BNS icon
5660
CALL
Scotiabank
BNS
$108B
$166K ﹤0.01%
3,475
-65,717
-95% -$2.69M
FEZ icon
5661
PUT
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.51B
$166K ﹤0.01%
5,000
-2,100
-30% -$67.3K
OMC icon
5662
PUT
Omnicom Group
OMC
$22.4B
$166K ﹤0.01%
2,000
+1,500
+300% +$113K
CCXI
5663
DELISTED
ChemoCentryx, Inc.
CCXI
$166K ﹤0.01%
66,714
+47,275
+243% +$172K
BMS
5664
PUT
DELISTED
Bemis
BMS
$166K ﹤0.01%
3,200
-1,000
-24% -$48.2K
NSM
5665
CALL
DELISTED
Nationstar Mortgage Holdings
NSM
$166K ﹤0.01%
16,800
-14,000
-45% -$149K
AMCC
5666
DELISTED
Applied Micro Circuits Corporation New
AMCC
$166K ﹤0.01%
25,687
-25,216
-50% -$145K
MMP
5667
PUT
DELISTED
Magellan Midstream Partners, L.P.
MMP
$165K ﹤0.01%
+2,400
New +$157K
PCBK
5668
DELISTED
Pacific Continental Corp
PCBK
$165K ﹤0.01%
+10,244
New +$157K
TCPI
5669
DELISTED
TCP International Hldgs Ltd.
TCPI
$165K ﹤0.01%
+135,348
New +$128K
GSIG
5670
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
$164K ﹤0.01%
+11,589
New +$149K
DNOW icon
5671
CALL
DNOW Inc
DNOW
$2.6B
$163K ﹤0.01%
9,200
-2,125
-19% -$32.7K
CBIO
5672
Crescent Biopharma
CBIO
$586M
$163K ﹤0.01%
273
-285
-51% -$146K
JAKK icon
5673
Jakks Pacific
JAKK
$297M
$163K ﹤0.01%
+2,186
New +$157K
NVGS icon
5674
CALL
Navigator Holdings
NVGS
$1.27B
$163K ﹤0.01%
10,100
+500
+5% +$7.29K
GRUB
5675
PUT
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$163K ﹤0.01%
3,250
-8,400
-72% -$371K

Similar funds

Goldman Sachs's Q1 2016 Portfolio in Review

As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.

  • Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
  • Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
  • Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
  • Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
  • Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
  • Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
  • Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.

Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.